ロード中...
Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition
BACKGROUND AIMS: We have shown previously that inhibition of the p38 mitogen-activated protein kinase (p38MAPK) directs the differentiation of human embryonic stem cell (hESC)-derived cardiomyocytes (hCM). We investigated the therapeutic benefits of intramyocardial injection of hCM differentiated fr...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3270940/ https://ncbi.nlm.nih.gov/pubmed/22040108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653249.2011.623690 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|